1 Department of Neurology, Azienda Socio Sanitaria Territoriale di Mantova, Mantova, Italy.
2 Department of Internal Medicine, Oslo University Hospital, Oslo, Norway.
Int J Stroke. 2019 Jan;14(1):12-22. doi: 10.1177/1747493018806157. Epub 2018 Oct 10.
Intra-arterial treatment of acute ischemic stroke requires changes to acute stroke services since most hospitals do not have on-site intra-arterial treatment facilities.
To identify models for delivery of intra-arterial treatment and to compare process performance and clinical and radiological outcomes of the different models.
We systematically searched the literature and contacted experts in the field. We performed a qualitative synthesis to identify models, and a quantitative review and meta-analysis of clinical and radiological outcomes under different organizational models.
The searches retrieved 148 publications, of which 27 were used for the identification and description of models, and 9 for the comparison of the different models. We identified four main models: the mother-ship, drip-and ship, mobile interventionist, and mobile stroke unit models. There were no randomized-controlled trials of the different models, but non-randomized comparisons were possible using data from 8 observational studies and 1 randomized-controlled trial of intra-arterial therapy, of a total of 4127 patients. Comparison between the mother-ship and drip-and-ship models showed no difference in survival (OR 0.81; 95% CI 0.63-1.03), favorable functional outcome (OR 0.96; 95% CI 0.73-1.25), or arterial patency (OR 0.89; 95% CI 0.73-1.08).
Different organizational models exist for intra-arterial treatment of acute ischemic stroke, but there is insufficient evidence to recommend a particular, universal model. Until one model can be shown to be superior, the choice of model should depend on local factors and patient characteristics.
由于大多数医院没有现场动脉内治疗设施,因此需要对急性脑卒中服务进行改变,以进行动脉内治疗。
确定提供动脉内治疗的模式,并比较不同模式的过程性能以及临床和影像学结果。
我们系统地搜索了文献,并联系了该领域的专家。我们进行了定性综合分析以确定模型,并对不同组织模型下的临床和影像学结果进行了定量审查和荟萃分析。
搜索共检索到 148 篇文献,其中 27 篇用于确定和描述模型,9 篇用于比较不同模型。我们确定了四种主要模型:母舰,滴注-运输,移动介入专家和移动脑卒中单元模型。没有针对不同模型的随机对照试验,但是使用 8 项观察性研究和 1 项随机对照试验的动脉内治疗数据,总共 4127 例患者,就可以进行非随机比较。母舰和滴注-运输模型之间的比较显示,在存活率(OR 0.81;95%CI 0.63-1.03),良好的功能结果(OR 0.96;95%CI 0.73-1.25)或动脉通畅性(OR 0.89;95%CI 0.73-1.08)方面无差异。
存在不同的组织模型用于急性缺血性脑卒中的动脉内治疗,但是没有足够的证据推荐特定的通用模型。在一种模型能够被证明具有优势之前,模型的选择应取决于当地因素和患者特征。